Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Conditions: Folliculotropic Mycosis Fungoides; Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Sezary Syndrome; Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8; Sta ge IIB Mycosis Fungoides and Sezary Syndrome AJCC v8; Transformed Mycosis Fungoides Interventions: Procedure: Extracorporeal Photopheresis; Biological: Mogamulizumab; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: City of Hope Medical Center; Nationa...
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials
